002412.SZ · 汉森制药
China A-shares · RS rating 90 · As of 2026-10-14
| Price | 8.57 CNY |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 24 / 96 / 88 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 34 / 38 / 28 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -19.1% |
| Distance from 52-week high | +38.9% |
| Market cap (USD) | $690.8M |